InvestorsHub Logo
Followers 0
Posts 55
Boards Moderated 0
Alias Born 01/04/2006

Re: None

Wednesday, 01/10/2007 10:03:42 PM

Wednesday, January 10, 2007 10:03:42 PM

Post# of 6489
Cephalon's IGF may be a way around one of DNA's patents (the manufacturing one, which is the one of most concern, if I recall correctly) but does not make the other two go away. But the other two, if I recall correctly, expire in 2010 anyhow.

But I doubt it is a simple or quick solution. Seems likely that a new iPlex, complexed from Cephalon's yeast-derived IGF, would have to undergo some manufacturing approvals, and perhaps a trial to prove substantial equivalence.

I do think that the possibility of a new iPlex with Cephalon is a good recourse for iNSM, and might even be achievable during the 2 years it may take to go thru the appeals process. If so, there might be an uninterrupted supply.

I am curious to hear the thoughts of our more bio-knowlegeable posters have to say about this possibility...Jelly, Dr. Bio, Rfoable?



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News